
Hunan Sundy Science and Technology Co., Ltd.
SZSE:300515.SZ
11.8 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 576.582 | 464.543 | 393.636 | 384.503 | 319.449 | 282.468 | 254.086 | 206.161 | 208.808 | 224.556 | 223.507 | 213.169 | 164.254 | 157.187 |
Cost of Revenue
| 266.242 | 191.679 | 161.42 | 163.04 | 147.564 | 111.591 | 111.756 | 92.475 | 90.746 | 103.985 | 96.018 | 92.743 | 68.406 | 65.596 |
Gross Profit
| 310.34 | 272.864 | 232.216 | 221.463 | 171.886 | 170.877 | 142.33 | 113.686 | 118.062 | 120.572 | 127.489 | 120.427 | 95.848 | 91.591 |
Gross Profit Ratio
| 0.538 | 0.587 | 0.59 | 0.576 | 0.538 | 0.605 | 0.56 | 0.551 | 0.565 | 0.537 | 0.57 | 0.565 | 0.584 | 0.583 |
Reseach & Development Expenses
| 65.067 | 52.596 | 44.649 | 41.753 | 32.077 | 33.667 | 29.403 | 26.792 | 23.228 | 20.206 | 18.558 | 14.375 | 0 | 0 |
General & Administrative Expenses
| 7.215 | 8.271 | 5.497 | 5.428 | 9.137 | 6.902 | 7.027 | 5.266 | 5.203 | 3.627 | 3.083 | 4.531 | 26.795 | 25.524 |
Selling & Marketing Expenses
| 33.285 | 33.977 | 73.118 | 67.887 | 60.325 | 78.744 | 64.66 | 55.301 | 50.202 | 46.539 | 44.322 | 45.616 | 31.928 | 29.458 |
SG&A
| 40.499 | 109.958 | 78.615 | 73.314 | 69.462 | 85.646 | 71.687 | 60.567 | 55.405 | 50.166 | 47.405 | 50.147 | 58.723 | 54.982 |
Other Expenses
| 44.903 | 54.443 | 0.028 | -0.369 | -0.219 | -0.072 | -0.167 | -0.107 | 14.204 | 17.39 | 13.03 | 15.745 | 12.61 | 7.119 |
Operating Expenses
| 150.469 | 216.997 | 131.984 | 125.984 | 96.056 | 123.601 | 105.258 | 88.273 | 91.46 | 84.893 | 80.571 | 78.417 | 60.796 | 57.042 |
Operating Income
| 159.871 | 55.867 | 110.209 | 103.643 | 83.803 | 51.456 | 38.677 | 26.835 | 25.238 | 30.838 | 42.144 | 37.451 | 30.2 | 30.501 |
Operating Income Ratio
| 0.277 | 0.12 | 0.28 | 0.27 | 0.262 | 0.182 | 0.152 | 0.13 | 0.121 | 0.137 | 0.189 | 0.176 | 0.184 | 0.194 |
Total Other Income Expenses Net
| -0.708 | -0.072 | 15.264 | -0.369 | -0.219 | -0.072 | -0.167 | 8.52 | 14.165 | 16.682 | 13.011 | 15.721 | 12.545 | 7.119 |
Income Before Tax
| 159.163 | 55.795 | 110.236 | 103.273 | 83.584 | 51.384 | 38.511 | 26.728 | 39.403 | 47.52 | 55.155 | 53.172 | 42.745 | 37.62 |
Income Before Tax Ratio
| 0.276 | 0.12 | 0.28 | 0.269 | 0.262 | 0.182 | 0.152 | 0.13 | 0.189 | 0.212 | 0.247 | 0.249 | 0.26 | 0.239 |
Income Tax Expense
| 15.009 | 1.021 | 12.965 | 12.911 | 10.197 | 6.744 | 3.721 | 2.919 | 4.617 | 5.348 | 8.124 | 6.833 | 4.85 | 3.396 |
Net Income
| 143.236 | 53.737 | 92.19 | 86.33 | 71.073 | 44.022 | 35.064 | 23.809 | 34.786 | 42.172 | 47.031 | 46.34 | 37.895 | 34.242 |
Net Income Ratio
| 0.248 | 0.116 | 0.234 | 0.225 | 0.222 | 0.156 | 0.138 | 0.115 | 0.167 | 0.188 | 0.21 | 0.217 | 0.231 | 0.218 |
EPS
| 0.71 | 0.26 | 0.45 | 0.42 | 0.35 | 0.22 | 0.18 | 0.12 | 0.4 | 0.28 | 0.31 | 0.31 | 0.25 | 0.23 |
EPS Diluted
| 0.71 | 0.26 | 0.45 | 0.42 | 0.35 | 0.22 | 0.18 | 0.12 | 0.4 | 0.28 | 0.31 | 0.31 | 0.25 | 0.23 |
EBITDA
| 176.939 | 71.289 | 121.35 | 114.023 | 94.456 | 61.977 | 47.42 | 33.071 | 46.032 | 55.661 | 63.581 | 62.47 | 41.306 | 38.837 |
EBITDA Ratio
| 0.307 | 0.153 | 0.308 | 0.297 | 0.296 | 0.219 | 0.187 | 0.16 | 0.22 | 0.248 | 0.284 | 0.293 | 0.251 | 0.247 |